Literature DB >> 23297720

Selection for hepatic resection: expert consensus conference.

Myrddin Rees1, Dominique Elias, Felipe J F Coimbra, Susan L Orloff.   

Abstract

Mesh：

Year:  2012        PMID： 23297720      PMCID： PMC3719915          DOI： 10.1111/j.1477-2574.2012.00568.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  10 in total

Review 1.  Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends.

Authors:  L Maggiori; D Elias
Journal:  Eur J Surg Oncol       Date:  2010-07       Impact factor: 4.424

2.  Resection of liver metastases--when is it worthwhile?

Authors:  M A Adson
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

3.  Major hepatic resections for metastatic colorectal cancer.

Authors:  M A Adson; J A Van Heerden
Journal:  Ann Surg       Date:  1980-05       Impact factor: 12.969

4.  Selection for hepatic resection of colorectal liver metastases: expert consensus statement.

Authors:  Reid B Adams; Thomas A Aloia; Evelyne Loyer; Timothy M Pawlik; Bachir Taouli; Jean-Nicolas Vauthey
Journal:  HPB (Oxford)       Date:  2013-02       Impact factor: 3.647

Review 5.  Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments.

Authors:  Franco Roviello; Stefano Caruso; Daniele Marrelli; Corrado Pedrazzani; Alessandro Neri; Alfonso De Stefano; Enrico Pinto
Journal:  Surg Oncol       Date:  2010-12-15       Impact factor: 3.279

6.  Detailed liver-specific imaging prior to pre-operative chemotherapy for colorectal liver metastases reduces intra-hepatic recurrence and the need for a repeat hepatectomy.

Authors:  Brett Knowles; Fenella K S Welsh; Kandiah Chandrakumaran; Tim G John; Myrddin Rees
Journal:  HPB (Oxford)       Date:  2012-02-28       Impact factor: 3.647

7.  Long-term survival following delayed presentation and resection of colorectal liver metastases.

Authors:  P J Swan; F K S Welsh; K Chandrakumaran; M Rees
Journal:  Br J Surg       Date:  2011-05-19       Impact factor: 6.939

8.  Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection.

Authors:  J G Fortner; J S Silva; R B Golbey; E B Cox; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

9.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

Authors:  Gunnar Folprecht; Thomas Gruenberger; Wolf O Bechstein; Hans-Rudolf Raab; Florian Lordick; Jörg T Hartmann; Hauke Lang; Andrea Frilling; Jan Stoehlmacher; Jürgen Weitz; Ralf Konopke; Christian Stroszczynski; Torsten Liersch; Detlev Ockert; Thomas Herrmann; Eray Goekkurt; Fabio Parisi; Claus-Henning Köhne
Journal:  Lancet Oncol       Date:  2009-11-26       Impact factor: 41.316

10.  Results of R0 resection for colorectal liver metastases associated with extrahepatic disease.

Authors:  Dominique Elias; Lucas Sideris; Marc Pocard; Jean-Francois Ouellet; Valérie Boige; Philippe Lasser; Jean-Pierre Pignon; Michel Ducreux
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344
  10 in total
  2 in total

Review 1.  Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.

Authors:  Emily Khoo; Stephen O'Neill; Ewan Brown; Stephen J Wigmore; Ewen M Harrison
Journal:  HPB (Oxford)       Date:  2016-04-20       Impact factor: 3.647

2.  Colorectal liver metastases: surgery versus thermal ablation (COLLISION) - a phase III single-blind prospective randomized controlled trial.

Authors:  Robbert S Puijk; Alette H Ruarus; Laurien G P H Vroomen; Aukje A J M van Tilborg; Hester J Scheffer; Karin Nielsen; Marcus C de Jong; Jan J J de Vries; Babs M Zonderhuis; Hasan H Eker; Geert Kazemier; Henk Verheul; Bram B van der Meijs; Laura van Dam; Natasha Sorgedrager; Veerle M H Coupé; Petrousjka M P van den Tol; Martijn R Meijerink
Journal:  BMC Cancer       Date:  2018-08-15       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.